These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

614 related items for PubMed ID: 18081037

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice.
    Li C, Liu F, Liang M, Zhang Q, Wang X, Wang T, Li J, Li D.
    Vaccine; 2010 Jun 11; 28(26):4294-300. PubMed ID: 20433802
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Recombinant virus-like particles of a norovirus (genogroup II strain) administered intranasally and orally with mucosal adjuvants LT and LT(R192G) in BALB/c mice induce specific humoral and cellular Th1/Th2-like immune responses.
    Nicollier-Jamot B, Ogier A, Piroth L, Pothier P, Kohli E.
    Vaccine; 2004 Mar 12; 22(9-10):1079-86. PubMed ID: 15003634
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes.
    McBurney SP, Young KR, Ross TM.
    Virology; 2007 Feb 20; 358(2):334-46. PubMed ID: 17011011
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Augmented induction of CD8+ cytotoxic T-cell response and antitumor effect by DCs pulsed with virus-like particles packaging with CpG.
    Song S, Wang Y, Zhang Y, Wang F, He Y, Ren D, Guo Y, Sun S.
    Cancer Lett; 2007 Oct 18; 256(1):90-100. PubMed ID: 17656012
    [Abstract] [Full Text] [Related]

  • 32. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus.
    Wang X, Zhang X, Kang Y, Jin H, Du X, Zhao G, Yu Y, Li J, Su B, Huang C, Wang B.
    Vaccine; 2008 Sep 19; 26(40):5135-44. PubMed ID: 18462848
    [Abstract] [Full Text] [Related]

  • 33. A study of systems for delivering antigens and plasmid DNA for intranasal immunization against tick-borne encephalitis virus.
    Goncharova EP, Ryzhikov AB, Bulychev LE, Sizov AA, Lebedev LR, Poryvaev VD, Karpenko LI, Il'ichev AA.
    Wien Klin Wochenschr; 2002 Jul 31; 114(13-14):630-5. PubMed ID: 12422616
    [Abstract] [Full Text] [Related]

  • 34. Distribution and phenotype of rotavirus-specific B cells induced during the antigen-driven primary response to 2/6 virus-like particles administered by the intrarectal and the intranasal routes.
    Di Martino C, Basset C, Ogier A, Charpilienne A, Poncet D, Kohli E.
    J Leukoc Biol; 2007 Oct 31; 82(4):821-8. PubMed ID: 17652448
    [Abstract] [Full Text] [Related]

  • 35. Efficient homologous prime-boost strategies for T cell vaccination based on virus-like particles.
    Schwarz K, Meijerink E, Speiser DE, Tissot AC, Cielens I, Renhof R, Dishlers A, Pumpens P, Bachmann MF.
    Eur J Immunol; 2005 Mar 31; 35(3):816-21. PubMed ID: 15724244
    [Abstract] [Full Text] [Related]

  • 36. Inactivated influenza vaccine adjuvanted with bacterium-like particles induce systemic and mucosal influenza A virus specific T-cell and B-cell responses after nasal administration in a TLR2 dependent fashion.
    Keijzer C, Haijema BJ, Meijerhof T, Voorn P, de Haan A, Leenhouts K, van Roosmalen ML, van Eden W, Broere F.
    Vaccine; 2014 May 19; 32(24):2904-10. PubMed ID: 24598720
    [Abstract] [Full Text] [Related]

  • 37. CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine.
    Eliasson DG, El Bakkouri K, Schön K, Ramne A, Festjens E, Löwenadler B, Fiers W, Saelens X, Lycke N.
    Vaccine; 2008 Feb 26; 26(9):1243-52. PubMed ID: 18243429
    [Abstract] [Full Text] [Related]

  • 38. Chimeric recombinant hepatitis E virus-like particles as an oral vaccine vehicle presenting foreign epitopes.
    Niikura M, Takamura S, Kim G, Kawai S, Saijo M, Morikawa S, Kurane I, Li TC, Takeda N, Yasutomi Y.
    Virology; 2002 Feb 15; 293(2):273-80. PubMed ID: 11886247
    [Abstract] [Full Text] [Related]

  • 39. Mucosal memory B cells retain the ability to produce IgM antibodies 2 years after oral immunization.
    Vajdy M, Lycke N.
    Immunology; 1995 Nov 15; 86(3):336-42. PubMed ID: 8550068
    [Abstract] [Full Text] [Related]

  • 40. Mucosal immunization of CD4+ T cell-deficient mice with an inactivated virus induces IgG and IgA responses in serum and mucosal secretions.
    Sha Z, Kang SM, Compans RW.
    Virology; 2005 Jan 20; 331(2):387-95. PubMed ID: 15629781
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.